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Introduction 
Liver Abscess noted in the writings of Hippocrates, was considered to be 
dreadful disease. It was uniformly fatal until a study by Ochsner and 
Debakey in 1938. They suggested an aggressive surgical approach to the 
liver abscess which reduced the mortality rates considerably. 
[1]
 Advances 
in radiological imaging which can diagnose the presence of liver abscess 
and its accurate anatomical localisation, combined with advances in  
pharmacotherapeutics and  critical care have shifted the treatment modality 
of choice from open surgical drainage to minimally invasive procedures. 
With many therapeutic options now available, the effective treatment of 
liver abscess is still controversial. Do the minimally invasive procedures 
provide effective drainage of the abscess with reduction of mortality when 
compared with open surgical drainage? This study aims at comparing the 
two methods of abscess drainage, open surgical and percutaneous 
aspiration in their effectiveness of providing cure in liver abscess. 
 
 
 
 
 
Review of literature 
History 
Liver abscess has been known since the time of Hippocrates (460 - 377 
BC). In one of his aphorisms he mentions “when abscess of the liver is 
treated by the cautery or incision, if the pus which is discharged is 'pure 
and white', the patient recovers, but if it resembles the lees of the oil as it 
flows, they die” .[2] 
Around 300 BC, Alexander the Great, after his campaign reaching the 
Indus region, where amoebiasis is endemic, felt sick and died on his return 
in Gedrosia desert. It is believed that is death was probably due to amoebic 
liver abscess.
 [3]
 
In 1818, George Ballingall, an army surgeon at the Madras establishment 
had made a note of an officer who got accidentally shot, resulted in 
draining of liver abscess and obtaining a complete cure.
 [4]
 
Napoleon Bonaparte, the French emperor in 18th century was exiled to a 
tropical island St. Helena after his defeat at the Battle of Waterloo. He had 
contracted a disease which was common on the island. Antommarchi, a 
physician appointed by Napoleon’s family described the features of 
Napoleon’s last illness. At the emperor's post-mortem, he had noticed “a 
cancerous ulcer which had its centre at the superior part along the small 
curve of stomach, communicating with the liver.” It is believed that 
Napoleon had died of amoebic liver abscess of the left lobe which had 
ruptured into stomach. 
[3]
 
In 1887, Robert Koch investigating cholera in Egypt and India had come 
across 2 cases of dysentery complicated by liver abscess. He identified 
Entamoeba histolytica in the capillary walls, adjacent to the abscess and 
found them similar to the ones in stool.
 [3]
 
Sir Charles Morehead, Professor of Medicine at Grants Medical College, 
Bombay in 1948, had described the first case of hepatic abscess in India.
 [3]
 
In 1891, Councilmann and Lafleur in their monograph coined the term 
“Amoebic Abscess of the liver” and described the occurrence of liver 
abscess as a complication of intestinal amoebiasis even in patients who did 
not have the symptoms of latter disease. 
[5]
 
Sir William Osler, in his 1892 edition of “The Principles and Practice of 
Medicine” described the major cause of liver abscess as “suppuration in the 
territory of portal vessels”. He also stated that “results from dysentery and 
other ulcerative affections of the bowels, appendicitis, occasionally typhoid 
fever, in rectal affections, and in abscesses in the pelvis.” He termed the 
process of portal bacteraemia with abscess formations as “suppurative 
pylephlebitis”. [6] 
Ochsner and DeBakey in 1938 described 137 cases of amoebic abscess and 
47 cases of pyogenic abscess. They also described the aggressive surgical 
management to decrease mortality which was a uniformly fatal disease 
until then. 
[1]
 Mcfadzean et al in 1953 first described the successful 
treatment of pyogenic liver abscess by percutaneous aspiration.
 [7]
 Whereas 
in 2005, a study by Tan et al showed open surgical drainage maybe a better 
modality compared to percutaneous drainage for the treatment of liver 
abscess. 
[8]
 Numerous studies have been published and yet effective 
treatment of liver abscess remains controversial. 
Epidemiology 
Liver abscess is a rare occurrence whose aetiology, diagnosis and treatment 
have changed over time. Traditionally, it has been classified into pyogenic 
abscess – caused by various bacteria, and Amoebic – caused by Entamoeba 
histolytica. Recent trends show increase in the incidence of fungal and 
mycobacterial abscess, probably due to increase in patients with AIDS and 
other forms of immunosuppression. 
[9]
 
Liver abscesses are the most common type of visceral abscess; in a report 
of 540 cases of intra-abdominal abscesses, pyogenic liver abscesses 
accounted for 48 percent of visceral abscesses and 13 percent of intra-
abdominal abscesses. 
[10]
 The annual incidence of liver abscess has been 
estimated at 2.3 cases per 100,000 and is higher among men than women.
 
[11]
 Risk factors include diabetes, hepatobiliary or pancreatic disease, and 
post liver transplantation. A primary invasive liver abscess syndrome due 
to Klebsiella pneumoniae has been described in East Asia indicating 
interplay between host and geographical factors. 
[12]
 With the effective 
treatment of conditions like appendicitis and other acute colonic diseases, 
there has been a shift in the aetiology and age distribution of patients 
presenting with hepatic abscess. Numerous studies have reported biliary 
tract disease to be the most frequent underlying lesion associated with 
pyogenic liver abscess, with a peak incidence in the seventh and eight 
decades. 
[11]
 
Worldwide, amoebiasis is the third most common parasitic cause of death. 
[13]
 Amoebic liver abscess is 7 to 10 times more common among adult men, 
despite equal gender distribution of intestinal amoebiasis. It is 
predominantly seen in the fourth and fifth decades of life. The reasons for 
these observations are not fully understood; suggested mechanisms include 
hormonal effects and a potential role of alcoholic hepatocellular damage in 
creating a nidus for portal seeding. Immigrants and travellers from endemic 
regions, people of low socioeconomic status, mentally retarded individuals 
and male homosexuals have a predilection for amoebic liver abscess. 
[9]
 
 
 
Pyogenic Liver Abscess 
Aetiology  
Liver is constantly exposed to the infective organisms from the 
gastrointestinal tract. Kupffer cells act as a filter for the clearance of micro 
organisms. Abscesses occur when normal hepatic clearance mechanism fail 
or the system is overwhelmed. 
The potential cause of liver abscess is classified as 
[14]
: 
1. Biliary. 
2. Portal vein. 
3. Haematogenous. 
4. Traumatic. 
5. Direct extension. 
6. Cryptogenic. 
30 – 40% of all pyogenic abscesses are due to diseases of the biliary 
system. 40% of these abscesses occur due to underlying malignancy. 
Obstruction of biliary tree, intrahepatic biliary stone, associated stricture, 
manipulation of biliary tract like cholangiography, percutaneous hepatic 
stents, endoscopic stent placement and biliary enteric anastomosis 
predispose patients to cholangitis and pyogenic liver abscess. 
[14]
 
Intestinal pathology is responsible for 20% of pyogenic liver abscess. 
Gastrointestinal perforation or bacterial translocation cause transient 
bacteraemia and resultant spread via the portal vein to the liver. 
Diverticulitis, perforated colonic carcinoma and other intra-abdominal 
abscess predispose to pylephlebitis and cause liver abscess. 
[14]
 
Gangrenous cholecystitis, perforated ulcers and subphrenic abscesses cause 
liver abscess by contiguous spread. Trauma to liver causes parenchymal 
necrosis and clot, which creates an ideal milieu for the seeding and 
proliferation of microorganisms and subsequent abscess formation. 
Haematogenous spread can occur from distant infection from heart, lungs, 
kidneys, bones, ears and teeth through the hepatic artery and cause about 
12% of pyogenic liver abscesses. Cryptogenic abscesses, those of unknown 
aetiology occur in 10 – 45% of patients who have co morbidities like 
diabetes, immunosuppression. 
[14]
 
Pathology  
The number, size, location of liver abscess is determined by the source. 
Portal, cryptogenic, and traumatic abscesses are solitary, large whereas 
biliary and arterial abscesses are small and multiple. 
[14]
 
Huang et al reported that liver abscess involved the right lobe in 63% of 
cases; the left lobe in 14% and 22% had bilobar disease. 
[11]
 The 
predilection for the right hepatic lobe can be attributed to anatomic 
considerations. 
[14]
  
 The right hepatic lobe receives blood from both the superior 
mesenteric and portal veins, whereas the left hepatic lobe receives 
inferior mesenteric and splenic drainage.  
 The right lobe contains a denser network of biliary canaliculi and, 
overall, accounts for more hepatic mass.  
 Studies have suggested that a streaming effect in the portal 
circulation is causative. 
 
Bacteriology 
Abscess cultures are positive for growth in 80 – 90% of cases, but blood 
cultures yield growth in 50 – 60%. E. coli, klebsiella sp, enterococci, 
pseudomonas are commonly isolated aerobic bacteria. 
[15]
 Bacteroides and 
fusobacterium are the commonly isolated anaerobes. 
[16]
  
The organisms commonly isolated from the abscess cavity and their 
frequency of isolation is described in the table below. 
 
 
Category of organisms % of patients 
Gram negative aerobes 50 – 70 
Eschericihia coli 35 – 45 
Klebsiella 18 
Proteus 10 
Enterobacter 15 
Serratia Rare 
Morganella Rare 
Acinetobacter Rare 
Gram positive aerobes 55 
Streptococcal species 20 
Enterococcus 10 
β – Streptococci 5 
α - Streptococci 5 
Staphylococcal sp 15 
Anaerobes 40 – 50 
Bacteroides 24 
Fusobacterium 10 
Peptostreptococcus 10 
Clostridium 5 
Actinomyces Rare 
Fungal 26 
Sterile 7 
 
Clinical features 
 
The clinical presentation of liver abscess is usually sub-acute and 
nonspecific, requiring high index of suspicion for diagnosis. The classic 
presentation triad of fever with chills, right upper quadrant pain and 
general malaise is rarely present. 
[15]
 The most common presenting 
symptom is fever with chills. The abdominal pain is constant dull aching, 
localised to the right upper quadrant. Associated diarrhoea is rarely present. 
Abscesses of the left lobe present with symptoms in the epigastric region. 
Associated features like malaise and weight loss are present when patients 
present late. Jaundice occurs when there is compression of the biliary tree. 
Pleuritic pain or pain at the tip of right shoulder occurs due to irritation of 
the right hemi-diaphragm. 
[14]
  
 
The following table shows the common signs and symptoms of 
presentation of patients with pyogenic liver abscess and their frequency of 
occurrence. 
 
 
 
 Symptom Percentage of pyogenic abscesses 
Fever 83 
Weight loss 60 
Pain 55 
Nausea and vomiting 50 
Malaise 50 
Chills 37 
Anorexia 34 
Cough or pleurisy 30 
Pruritis 17 
Diarrhoea 12 
Signs  
Right upper quadrant tenderness 52 
Hepatomegaly 40 
Jaundice 31 
Right upper quadrant mass 25 
Ascites 25 
Pleural rub or effusion 20 
 
Complications 
Complications of liver pyogenic liver abscess can be classified into 
1. Local complications include: 
 Rupture [17]: 
o Into the peritoneal cavity resulting in peritonitis. 
o Into the pleural cavity causing empyema and hepatopleural 
fistula. 
o Into the pericardial cavity from an abscess of the left lobe. 
o Into adjacent organ and fistulise into stomach, colon, small 
bowel, or kidney. 
o Subphrenic space resulting in subphrenic space. 
o Into biliary tract resulting in haemobilia. 
 Liver Failure. 
 Acute pancreatitis. 
2. Vascular complications include: 
 Hepatic vein thrombosis. 
 Portal vein thrombosis. 
 Hepatic artery pseudo – aneurysm due to erosion of abscess 
into the hepatic artery. 
3. Systemic septic complications are common in diabetic patients who 
are infected with Klebsiella pneumonia through haematogenous 
dissemination. 
[18]
 
 Endophthalmitis or uveitis,  
 Pulmonary abscess,  
 Brain abscess and/or purulent meningitis,  
 Bacteriuria and/or prostate abscess,  
 Osteomyelitis and/or pyogenic arthritis, and  
 Psoas abscess. 
Amoebic liver abscess 
Aetiology 
Amoebic liver abscess is caused by Entamoeba histolytica. After fecal oral 
transmission, the infective quadrinucleate cyst passes through the stomach. 
The trophozoite is released after the pancreatic enzymes digest the outer 
cyst wall. Usually, the trophozoite multiplies in the intestine with no 
invasion resulting in amoebic dysentery alone or asymptomatic carrier. In a 
few patients, the trophozoite invades the intestine and travels along the 
veins and reaches the liver and form an abscess cavity. 
[14]
 
 
 
Life cycle of Entamoeba histolytica 
 
 
 
Pathology 
Entamoeba histolytica as implied by its name lyses through the tissues 
through a complex set of interactions, cell adherence, cell activation and 
subsequent release of enzymes results in cell necrosis. Hepatic amoebic 
abscess more commonly involves the right lobe of liver. It is a result of 
liquefactive necrosis of the liver forming a cavity of blood and liquefied 
liver tissue. The hepatic necrosis continues until it reaches the Glisson's 
capsule. As the capsule is resistant to hydrolysis, the amoebic liver abscess 
tends to abut the liver capsule and the cavity is crisscrossed by portal 
triads. 
[19]
 
Early on, the infection of liver results in amoebic hepatitis which progress 
to from multiple small abscess which later coalesce to form a single large 
hepatic abscess. The abscess itself contains acellular fluid which is 
red/brown and yellow in colour and similar to “anchovy paste” in 
consistency. Trophozoites are absent in the abscess but reside in the 
necrotic tissue surrounding the abscess. 
[20]
 
Clinical presentation 
Majority of amoebic liver abscess occur in the young adult males. The 
presentation may be acute, with fever and right upper quadrant pain, or sub 
acute, with weight loss. History of alcohol abuse is common.  
The following table shows the common signs and symptoms of 
presentation of patients with pyogenic liver abscess and their frequency of 
occurrence. 
 
 
Symptom 
Percentage of Amoebic liver 
abscesses 
Pain 90 
Fever 87 
Nausea and vomiting 85 
Anorexia 50 
Weight loss 45 
Malaise 25 
Diarrhoea 25 
Cough or pleurisy 25 
Pruritis <1 
Signs  
Hepatomegaly 85 
Right upper quadrant tenderness 84 
Pleural effusion or rub 40 
Right upper quadrant mass 12 
Ascites 10 
Jaundice 5 
 
 
Complications 
 Secondary bacterial infection of the abscess can occur. 
 Pleural manifestations may include development of a sympathetic 
serous effusion. 
 Rupture is the most common complication of amoebic liver abscess. 
Rupture may occur into peritoneum, pleural cavity or pericardium, 
the latter being common with left lobe abscess. Rupture may also 
occur into the stomach and colon. Abscess rupture into the pleural 
space results in an amoebic empyema; rupture into the lung can lead 
to consolidation, abscess formation, or a hepatobronchial fistula 
resulting in a spontaneous cure. 
[21]
 
 Metastatic amoebic abscess can occur in brain, lung, skin and 
genitourinary tract, presumably due to haematogenous spread from 
the intestinal infection. 
[21]
 
 Compression syndrome: A posterior located Amoebic liver abscess 
of the right lobe may manifest as hepatic outflow obstruction or 
inferior vena cava obstruction. Clinical features include bilateral 
pedal oedema, ascites and visible veins on anterior and posterior 
abdominal wall. These features disappear after aspiration of the 
abscess. 
[22]
 
 
Differential Diagnosis 
[19]
 
1. Right subphrenic abscess. 
Recent abdominal surgery, inflammatory or perforating conditions of 
the intra abdominal viscera or abdominal trauma may suggest the 
diagnosis of subphrenic abscess; a lung and liver scan may help in 
differentiating it from the liver abscess. 
2. Malignancy of liver. 
This may be a primary liver malignancy or secondary metastatic 
deposits in the liver. A hard nodular and markedly enlarged liver 
both with and without jaundice suggests malignancy. 
3. Acute cholecystitis. 
Sudden onset of severe pain in right upper quadrant, nausea, 
vomiting fever and minimal icterus should suggest the diagnosis of 
acute cholecystitis. Murphy’s sign will be positive. 
4. Hydatid cyst of liver. 
Patients with hydatid cyst usually present with a mass in the upper 
abdomen. Cardinal features of liver abscess like fever, pain and 
tenderness are absent. Hydatid thrill can be elicited.  
5. Alcoholic hepatitis. 
This condition occurs in chronic alcoholics. Jaundice is more 
frequent in alcoholic hepatitis.  
6. Viral Hepatitis. 
Although liver abscess and viral hepatitis are both common in under 
developed countries, differentiating the two is not difficult. 
Complete loss of appetite, nausea, vomiting and absence of pain all 
favour the viral hepatitis. 
7. Congestive liver of congestive cardiac failure or constrictive 
pericarditis. 
Oedema, breathlessness and hepatomegaly occurring occasionally in 
liver abscess may be mistaken for congestive cardiac failure. 
Absence of fever, severe pain, diffuse hepatomegaly and presence of 
engorged neck veins along with signs in the chest suggest 
involvement of heart. 
8. Acute Abdomen 
Occasionally “Reflex ileus” in association with persistent vomiting, 
constipation and distension provides a picture which is difficult to 
distinguish from an acute intestinal obstruction. 
Investigations  
Haematological investigations: 
Almost all patients with liver abscess have a haemoglobin level <12g% and 
a haematocrit level < 36%.   There will be associated leukocytosis >10,000 
cells/mm3, predominantly neutrophilic with absence of eosinophilia. 
[23]
 
Liver function tests 
Elevation of bilirubin > 2 g/dl is common with pyogenic liver abscess. In 
an acute liver abscess, serum alkaline phosphatase will be normal and 
alanine transferase will be elevated and a reverse occurs in a chronic liver 
abscess. Hypoalbuminemia (Albumin <3g/dl) is present in about 90 % of 
the patients. 
[14]
  
Stool examination 
The role of wet mount stool examination is limited as less than 30-40% of 
patients with amoebic liver abscess have concomitant intestinal 
amoebiasis. Microscopically similar but non-pathogenic Entamoeba dispar 
contributes for the high false positive rate. 
[24]
  
Examination of the stool is done by a combination of wet mount, iodine-
stained concentrates, and trichrome-stained preparations. Haematophagous 
trophozoites of E histolytica require at least 3 fresh specimens as the 
trophozoites are very sensitive and may be excreted intermittently. Cysts 
must be differentiated morphologically from nonpathogenic Entamoeba 
hartmanni, Entamoeba coli, and Endolimax nana. Nonpathogenic E dispar 
cannot be differentiated morphologically and require fecal antigen 
detection. 
[9]
 
ELISA targeting the galactose inhibitable adherence protein of E. 
histolytica helps to differentiate between the two amoebae. Stool antigen 
detection facilitates early diagnosis before an antibody response. The 
drawbacks are the requirement for fresh, unpreserved stool specimens and 
the lack of intestinal amoebiasis in as many as 60% of patients with 
amoebic liver abscess. 
[13]
 
The PCR stool test is highly sensitive for detection of E histolytica and for 
distinguishing nonpathogenic amoebas. However, this test is expensive and 
less sensitive than ELISA for stool antigen. Real-time (rapid) PCR is being 
developed and is a sensitive test for detection of E histolytica. 
[25]
 
Serology 
Indirect haemagglutination tests targeting the antibodies against E 
histolytica were used in the past. These tests remain positive after infection 
for many years and interpretation is difficult in patients from endemic 
areas.  
These tests have been replaced by enzyme immunoassay (EIA) which is 
rapid and inexpensive. The EIA test detects antibodies specific for E 
histolytica in approximately. 
[26]
  
 95% of patients with extraintestinal amoebiasis,  
 70% of patients with active intestinal infection, and 
 10% of persons who are asymptomatic cyst passers. 
The EIA serology reverts to negative in 6 – 12 months following 
eradication of infection. Even in highly endemic areas, fewer than 10% of 
patients who are asymptomatic have positive amoebic serology findings.
[26]
 
Initial test results may be negative in as many as 10% of patients with 
amoebic liver abscess, but repeat serology testing within a week will 
usually be positive. 
Entamoeba histolytica galactose lectin antigen is detectable by Enzyme-
linked immunosorbent assay (ELISA) in 75% of patients with amoebic 
liver abscess [26]. Initial antigen seropositivity is 96% with a reversal rate 
of 82% after 1 week of treatment with metronidazole. This test is useful for 
patients who present acutely, before an antibody response occurs. The 
serum sample is to be obtained before initiation of treatment, as medical 
therapy leads to rapid antigen loss. This test can be used for rapid diagnosis 
in highly endemic areas, where serology can be misleading. 
Rapid testing for antigen and antibodies are being currently developed and 
are showing a promising future.
[26]
 
 
 
Blood culture 
Blood culture reveals growth in only about 50 % of cases. But there has 
been a poor correlation between the organism isolated from the abscess 
itself and the blood culture due to polymicrobial nature of the disease. 
Diagnostic Aspiration 
Under CT scan or ultrasound guidance, needle aspiration of cavity material 
can be performed. 
Needle aspiration enables rapid recovery of material for microbiologic and 
pathologic evaluation. When the diagnosis is in doubt, it helps to identify 
whether the abscess is amoebic or pyogenic. 
[26]
 
Needle aspiration of the abscess can be performed with the initial 
diagnostic procedure. 
Radiological investigations 
Roentgenography 
Chest X ray is abnormal in about 50% of cases. 
[19]
 Features include 
1. Elevated right hemi diaphragm. 
2. Pleural effusion. 
3. Atelectasis. 
4. Pneumonitis. 
Abdominal X ray may reveal 
1. Hepatomegaly. 
2. Gas within the abscess cavity due to 
a. Infection by gas forming organisms. 
b. Secondary infection of amoebic abscess. 
c. Prior percutaneous intervention. 
d. Rupture into a hollow viscous. 
3. Air in the portal vein if associated pylephlebitis is present. [14] 
4. Aerobilia may be present if cholangitis is present. [27] 
Absence of the findings however doesn’t rule out liver abscess. 
Ultrasonography 
Ease of access and low cost has made ultrasonography a boon in evaluation 
and treatment of live abscess. USG can identify lesions as small as 2cm. 
The typical lesion is a hypo echoic round lesion with an echogenic wall, 
acoustic enhancement and internal echoes. Ultrasonography allows for 
close evaluation of the biliary tree and simultaneous aspiration of the 
cavity. The major benefits of this technique are its portability and 
diagnostic utility in patients who are too critical to undergo prolonged 
radiologic evaluation or to be moved out of monitored setting. 
[14]
 
 
The drawbacks of USG include. 
[19]
 
1. Doesn’t visualize the dome of liver. 
2. Multiple micro abscesses may not be seen. 
3. Fatty infiltration increase echogenicity of liver and decrease the 
sensitivity of the study. 
4. Operator dependence affects its overall sensitivity. 
CT scan 
[14]
 
Computed tomography scanning has the advantage of being able to detect 
intrahepatic lesions as small as 0.5 cm and also image the entire abdomen.  
A classical lesion of liver abscess will be a hypo dense cystic lesion with 
thick segmental wall enhancement and surrounding low density oedema. A 
central large lesion can be surrounded by adjacent “daughter” abscess 
representing coalescing of multiple small abscess – Cluster sign, is 
suggestive of bacterial cause.
 [28]
 
MRI 
Magnetic resonance imaging can better characterize hepatic lesions 
compared to CT. MRI can distinguish liver abscess from other cystic and 
necrotic lesions. 
[9]
 High cost, length of study and lack of easy access for 
drainage procedure has limited the usefulness in management of liver 
abscess.
 [11]
 
Other imaging 
Technetium – 99m liver scanning is useful test for differentiating an 
amoebic liver abscess from a pyogenic abscess; however, it is not a first-
line test. 
[26]
 
Amoebic liver abscesses do not contain leukocytes; they appear as cold 
lesions on hepatic nuclear scanning, with a typical hot halo or a rim of 
radioactivity surrounding the abscess. 
[26]
 
In contrast, pyogenic liver abscesses contain leukocytes and, therefore, 
typically appear as hot lesions on nuclear scanning. 
Gallium scanning is helpful in differentiating pyogenic abscess but requires 
delayed images, which makes the test less helpful. Gallium and 
Technetium 99m scans have largely been abandoned in their role of 
investigating and treatment of liver abscess due to advances in CT and 
USG. 
[9]
 
Treatment 
Pyogenic liver abscess 
An untreated hepatic abscess is nearly uniformly fatal due to the 
complications that follow. Management of pyogenic liver abscess involves 
appropriate antibiotic therapy and drainage of abscess, followed by 
identifying the source of abscess and successful treatment of the same. 
Appropriate antibiotic therapy involves the identification of the organism 
by blood culture or culture of the pus from the abscess. Treatment is 
initiated with broad spectrum antibiotics covering gram positive and 
negative organisms and anaerobic bacteria. A prolonged course of 
antibiotics lasting 4 – 6 weeks is required as there is a perception of 
presence of avascularity in the abscess. 
[14]
  
The differences in clinical presentation of pyogenic and amoebic liver 
abscess are given in the table below. 
[19]
 
Clinical features 
Amoebic liver 
abscess 
Pyogenic liver 
abscess 
Age (years) 20 – 40 >50 
Male : Female >10:1 1.5:1 
Solitary vs. Multiple Solitary 80% Solitary > 50 % 
Location 
Usually Right 
lobe 
Usually right 
lobe 
Travel to endemic area Yes No 
Diabetes and other forms of 
Immunosuppression 
No Yes 
Alcohol use Common Common 
Jaundice Uncommon Common 
Elevated ALP Common Common 
Positive blood culture No Yes 
Positive amoebic serology Yes No 
 
Drainage procedures 
Most liver abscesses require some form of drainage, whether it is closed 
aspiration, percutaneous drainage or surgical. 
Closed aspiration 
Giorgio and colleagues reported a series of 115 patients who underwent 
percutaneous aspiration and reported a 98.3 % success rate with no 
mortality or morbidity. 
[29]
 Percutaneous aspiration is usually undertaken 
under USG or CT guidance. At present, the indications for closed needle 
aspiration include 
[14]
: 
1. Lack of improvement with subsidence of symptom and signs in 48-
72 hours after medical line of treatment. 
2. Abscess greater than 5 cm in diameter. [19]. 
Percutaneous Aspiration is not recommended in patients with 
[14]
 
1. Multiple large abscesses. 
2. A known intra- abdominal source that requires surgery. 
3. An abscess of unknown aetiology. 
4. Abscess that would require transpleural drainage. 
5. Ascites. 
 
Complications 
1. Haemorrhage: External bleeding from punctured site is usually of 
short duration and is only about 5 to 10ml. Inter or intraperitoneal 
haemorrhage can occur from perforation of portal vein, hepatic veins 
and aberrant or intercostal arteries. Intrahepatic haematoma can 
occur but usually is asymptomatic. Rupture of intrahepatic 
haematoma into a bile duct may lead to haemobilia. 
2. Puncture of gall bladder is usually followed by biliary peritonitis and 
surgical intervention may be warranted. 
3. Pleurisy, perihepatitis and pneumothorax can occur. [29] 
4. Death due to vagal shock can occur very rarely. 
Percutaneous aspiration is less invasive, less expensive; however 
recurrence rates and the requirement for surgical intervention may be 
greater who undergo aspiration alone. 
Catheter drainage 
In 1998, a randomised control trial conducted by Rajak et al compared 
percutaneous aspiration to catheter drainage. 
[30]
 They reported a 60% 
success with percutaneous aspiration versus a 100% success with catheter 
drainage. The indications and complications are similar to percutaneous 
aspiration. 
Advantages 
1. It can be used as therapeutic and diagnostic procedure. 
2. Relatively safe economic and informative. 
3. Follow up of the resolution of the abscess cavity can be ascertained 
by studies like air cavitogram or by use of dyes. 
[31]
 
Disadvantages 
1. Catheter blockade can occur and require re – insertion. 
2. Can’t be used when there is evidence of threatening rupture. 
Open surgical drainage 
Surgical drainage had been an accepted treatment modality since 1938.
 [1]
 
Initially abscesses were drained extraperitoneally to avoid contamination of 
the peritoneum. 
[9]
 With the advent of antibiotics and improvements in post 
operative care, transperitoneal exploration is a safe surgical approach. The 
transperitoneal approach has the advantage of the ability to 
[14]
: 
1. Treat the inciting pathology in the remainder of abdomen or pelvis. 
2. Gain access and exposure of entire liver for evaluation and 
treatment. 
3. Access the biliary tree for cholangiography and bile duct 
exploration. 
 
Surgical drainage is currently reserved for patients that 
[11]
  
1. Ruptured liver abscess. 
2. Have failed non – operative therapy. 
3. Those needing surgical treatment of the underlying source. 
4. Multiple macro abscesses.  
5. Concomitant ascites. 
For high posterior lesions, a posterior transpleural approach is advocated. 
This allows easier access to the abscess, but the advantage to identify 
multiple lesions or a concurrent intra-abdominal pathology is lost. 
Laparoscopic surgical drainage 
[32, 33] 
Laparoscopic drainage is an attractive alternative for patients requiring 
open surgical drainage. Laparoscopic surgery has the advantages of both 
open surgery and the minimal invasiveness of percutaneous drainage. The 
advantages of laparoscopic surgery in terms of reduced analgesia 
requirements, reduced morbidity, faster postoperative recovery and shorter 
hospital stay compared to laparotomy are well documented. Laparoscopic 
localization of liver abscess may be more difficult than at open surgery due 
to lack of tactile feedback. However, aspiration with a long endoscopic or 
spinal needle may aid localization. Laparoscopic ultrasonography is useful 
in this respect. 
There is no single best treatment modality for pyogenic liver abscess. 
Therapy has to be individualised to each patients to achieve the best 
possible outcome. 
Factors associated with poor outcome in Pyogenic liver abscess 
[14]
: 
 Age >70 years. 
 Diabetes mellitus. 
 Associated malignancy. 
 Biliary aetiology. 
 Multiple abscesses. 
 Septicaemia. 
 Polymicrobial bacteraemia. 
 WBC count >20,000 cells/mm3. 
 Increasing bilirubin. 
 Increasing SGOT. 
 Albumin <2 g/dL. 
 Aerobic Abscess. 
 Significant complication like rupture and peritonitis. 
 
 
 
Follow up 
Patients will require prolonged parenteral antimicrobial therapy that may 
continue after discharge. Radiologic evaluation to document progress of 
therapy after discharge is required. 
Amoebic liver abscess 
Majority of the amoebic abscess can be treated with medical management. 
Drainage procedures, regardless of the approach, are reserved for patients 
with questionable diagnosis or when complications ensue. 
Anti amoebic drugs 
Classification 
[34]
 
1) Tissue amoebicides. 
a) Intestinal and extraintestinal amoebiasis: 
i) Nitroimidazoles: Metronidazole, Tinidazole, Secnidazole, 
Ornidazole, Satranidazole. 
ii) Alkaloids: emetine, Dehydroemetine. 
b) For extraintestinal amoebiasis only: Chloroquine. 
2) Luminal amoebicides: 
a) Amide: Diloxanide furoate. 
b) 8 – Hydroxyquinolones: Quinidochlor, Iodoquinol. 
c) Antibiotics: Tetracyclines. 
Metronidazole: Prototype Nitroimidazole compound. It has broad spectrum 
cidal activity against protozoa and anaerobic bacteria. Achieves high 
concentration in liver with small amounts of drug, absorbs rapidly, rapidly 
excreted without cumulative effect. The current recommendation for liver 
abscess is 750 mg TDS for 10 days. In serious cases of liver abscess 1g 
may be infused IV followed by 0.5g 12
th
 hourly till oral therapy is 
instituted. For mild intestinal disease 400mg TDS for 7 days is 
recommended. Adverse effects include Headache (10%), dizziness, nausea, 
anorexia, Heavy coating of tongue, brownish urine, metallic taste, 
ataxia(<1%), seizures, paraesthesias, disulfiram like reaction with 
alcohol.
[34]
 
Tinidazole: A congener of Metronidazole with slower metabolism resulting 
in less frequent dosing. 2g OD for 3 days or 0.6g BD for 5 – 10 days. The 
incidence of adverse effects is lower. 
Chloroquine: useful in hepatic amoebiasis only as it is completely absorbed 
in the upper intestine without achieving concentration in the intestinal wall. 
Amoebae do not develop resistance to chloroquine but duration of 
treatment is longer and relapses are more frequent. Dose for amoebic liver 
abscess is 600mg base for 2 days followed by 300mg base for next    2 – 3 
weeks. It is contraindicated in patients with retinopathy and psoriasis. 
Other adverse effects include G.I. disturbances, headache, visual 
disturbances and Pruritis. 
Diloxanide furoate: is a highly effective luminal amoebicide which directly 
kills the trophozoites responsible for cyst production. Effective in cyst 
passers and therefore used for treatment of asymptomatic carriers, family 
members and intimate contacts of patients diagnosed with liver abscess. 
Dosage is 500 mg TDS for 10 days. Adverse effects include flatulence, 
nausea, vomiting, pruritis and urticaria. 
Therapeutic protocol 
[9]
 
Metronidazole is the current drug of choice. It is administered as a single 
drug (750mg TDS) after diagnosis, with concomitant correction of 
hypoprothrombinemia, hypoproteinemia and anemia. If improvement 
occurs within 48 – 72 hours, metronidazole is continued till 14 days. A 
luminal agent such as Diloxanide furoate (500 mg PO, TDS. x 10 days) 
must be administered following metronidazole therapy for the eradication 
of intestinal infection as a part of the complete treatment. In patients who 
do not respond, Emetine or Dehydroemetine is added.  
Freeman et al in their study of 36 patients with amoebic liver abscess 
showed percutaneous needle aspiration is safe, enhances clinical recovery, 
and accelerates resolution particularly in patients with large abscess 
cavities. 
[35]
  
Therapeutic aspiration of amoebic liver abscess is considered when there 
are 
[36]
: 
1. High risk of abscess rupture, as defined by cavity size greater than 5 
cm;  
2. Left lobe liver abscess, which is associated with higher mortality and 
frequency of peritoneal leak or rupture into the pericardium;  
3. Failure to observe a clinical response to medical therapy within 5-7 
days; and  
4. A difficulty in differentiating from a pyogenic liver abscess. 
5. Age older than 55 years. 
In endemic areas as many as 50% of patients may require aspiration, as 
many present late and have multiple abscesses. 
Routine needle aspiration offers only minimal benefit over medical care 
alone. Needle aspiration is avoided for uncomplicated amoebic liver 
abscess unless one of the above indications exists. Prompt medical care 
decreases the need for aspiration. 
Catheter drainage is considered when large volume of abscess needs to be 
drained. Rajak et al demonstrated that catheter drainage may be better 
compared to needle aspiration, but the average time for clinical 
improvement, mean hospital stay were similar in the two groups.
[30]
 
Generally, surgical drainage is not necessary and should be avoided; 
however, open surgical drainage is considered when the abscess is 
inaccessible to needle drainage or a response to therapy has not 
occurred.
[14]
 
Evidence of pulmonary, peritoneal or pericardial extension is a dreaded 
complication and an indication for drainage of the liver abscess with an 
intercostal tube or catheter into a closed-circuit collection system. Failure 
to adequately control the abscess by these means or when there are 
increasing signs or features of peritonitis or fistulisation into a hollow 
viscus or secondary infection with septicaemia constitutes an indication for 
laparotomy. 
[9, 14, 19] 
Factors associated with poor outcome in Amoebic liver abscess. 
[14]
. 
 Serum bilirubin >3.5 mg/dL. 
 Encephalopathy. 
 Albumin <2 g/dL. 
 Multiple abscess cavities. 
 
 
Follow up 
After clinical cure, patients are usually asymptomatic and ultrasonographic 
follow up demonstrates evidence of persistent hypoechoic lesion. The 
mean time for the disappearance of the sonographic abnormality is 6 - 9 
months. The patterns of resolution seen on sonographic follow up 
include
[37]
: 
 Type I: where complete disappearance of the cavity occurs within 3 
months,  
Type II: a rapid reduction till 25% of the original cavity size and then a 
delayed resolution. Clinical resolution does not correlate with radiologic 
resolution; the result of the therapeutic intervention is monitored by clinical 
criteria rather than USG. 
Fungal liver abscess. 
It is an unusual cause of liver abscess whose recent incidence is on the rise. 
Aetiology. 
The common causative organisms causing liver abscess include: 
 Candida species like C. albicans, C. glabrata. 
 Cryptococcus sp. 
 Asperigillus sp. 
Predisposing factors. 
Fungal liver abscess is more common in patients in  
 Immunocompromised states. 
 Diabetes mellitus. 
 Hematologic malignancies like lymphoma and leukemia. 
Few cases are reported in immune competent patients also. 
[38]
 
Investigations 
Ultrasonography and CT reveal multiple abscesses which are suggestive of 
fungal nature in the predisposed patients. 
Fungal culture and microscopy of the aspirate are diagnostic. 
Treatment  
Amphotericin B and Fluconazole are the drugs of choice. 
Percutaneous aspiration can be done in cases where conservative 
management fails. 
Open surgical drainage is reserved for resistant cases. 
FDG PET helps in the evaluation of treatment response in fungal liver 
abscesses. 
[39]
 
 
Tubercular Liver abscess. 
Tubercular liver abscesses are extremely rare. It was first described by 
Bestowe in 1858. 
Etiology 
Tubercular liver abscess is most commonly due to haematogeneous spread 
from co existing pulmonary or gastro intestinal tuberculosis. Formation of 
tubercular liver abscess in patients with miliary tuberculosis is also 
explained. 
[40]
 
Clinical features. 
The clinical features are non specific which include fever, abdominal pain, 
nausea and anorexia. 
Jaundice is rarely seen. 
Hepatomegaly with smooth enlargement and right hypochondriac 
tenderness are the most common signs. 
[41]
 
Investigations  
USG and CT scan reveal either granulomatous tubercle, calcification 
depending on the activity of the disease. ‘Honey comb’ pattern of 
septations or ‘cluster sign’ may be evident on CT scan. [42, 43] 
Confirmation of the diagnosis is made by demonstrating AFB in the pus 
aspirate by microscopy or culture. 
PCR is a useful investigation in diagnosis of tubercular liver abscess and 
helps to differentiate M. tuberculosis from other mycobacterium. 
Treatment  
Antitubercular therapy using Isoniazid, Rifampicin, Pyrizinamide and 
Ethambutol for a period of 1 year can be considered in all patients. 
Percutaneous aspiration is a useful adjunct to antitubercular therapy. 
Prognosis is generally good for isolated tubercular liver abscess. 
 
 
 
 
 
 
 
 
 
Objectives 
1. To study the etiology, clinical manifestations of liver abscesses. 
2. To know the clinical response in patients with liver abscess, 
undergoing open surgical drainage and percutaneous needle 
aspiration.  
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
Patients admitted at Chengalpattu Medical College and Government 
hospital during October 2010 to October 2012 and diagnosed with liver 
abscess were included into the study. 
Inclusion criteria. 
1. Patients aged between 18 and 65 years admitted with 
a. A diagnosis of liver abscess with USG/ CT with size > 5cm in 
diameter. 
Exclusion criteria. 
1. Patients aged above 65 and below 18 years. 
2. Patients with liver abscess with size <5cm in diameter. 
3. Patients with liver abscess ruptured into peritoneal, pleural or 
pericardial cavity. 
4. Patients with liver abscess and coexisting ascites. 
5. Patients who do not consent for the study. 
Patient data collection 
A detailed history was collected from the patients who were selected for 
the study. The investigations were done and recorded as in the proforma. 
All patients received intravenous Ciprofloxacin 200 mg bd and 
Metronidazole 800 mg tds received as the initial treatment. Patients were 
divided into two groups and consent was taken regarding the procedure 
being undertaken.  
Group I underwent USG guided percutaneous needle aspiration. 
Group II received open surgical drainage. 
Patients’ coagulation profile was normalised before any intervention. 
Percutaneous needle aspiration. 
 The patient was kept NPO for six hours.  
 0.6 mg Atropine was injected to counteract vagal attack.  
 Aspiration was undertaken in an operation theatre with precautions 
for asepsis.  
 The site and depth of abscess was assessed and marked using USG 
guidance prior to the procedure.  
 The patient was put in semi-recumbent position, leaning against a 
backrest.  
 The selected area for aspiration was infiltrated with 5% Xylocaine 
after surgical draping.   
 Percutaneous aspiration was done with 18 gauge large bore needle. 
Aspiration was done using 10 ml syringe and continued until no 
more pus could be evacuated or until patient became distressed.  
 The aspiration site was sealed with tincture Benzoin. An adhesive 
plaster covering the right lower chest was applied.  
 The aspirated pus was sent for culture and sensitivity or microscopy 
accordingly.  
 Adequate analgesia was provided for the patient. 
 Patient was observed for twenty four hours with monitoring of the 
temperature, pulse, respiratory rate and abdominal girth to identify 
any signs of haemorrhage or peritonitis.  
 Patients were started orally the next day as tolerated.  
Open surgical drainage. 
 Patients were made to fast for at least six hours and abscess localised 
by USG and marked.  
 General or epidural anaesthesia was administered.  
 With patient in supine position and meticulous surgical toileting of 
the abdomen was done. The abdomen was opened with a midline 
vertical incision.  
 The liver was isolated from the rest of the peritoneal cavity by 
packing surgical mops. The abscess site was confirmed by needle 
aspiration.  
 A hepatotomy was made with an electrocautery to open the abscess 
cavity. The abscess is completely drained out with suction. A 
thorough wash was given with saline.  
 Care was taken to not break inter - running biliary radicles within the 
abscess cavity. A thorough examination of the intra – abdominal 
contents was made to rule out other intra – abdominal pathology.  
 Large bore tube drain was placed and brought out through a separate 
stab incision.  
 Abdomen was closed in layers after confirming the instrument and 
mopp count.  
 Patient was monitored regularly with watch on the temperature, 
pulse, respiration in the post operative period. 
 Oral feeds were started as tolerated by the patient. Drains were 
removed accordingly after confirming that there was no bile leak. 
Post procedure follow up 
Patients were examined daily for clinical improvement. Improvement of 
pain, fever, anorexia, and hepatomegaly were considered as a criterion for 
successful treatment. Complications arising from either of the procedures 
were noted and appropriate measures were undertaken. 
Ultrasonography was done as indicated. Relapses were noted and repeat 
aspirations were performed when necessary.  
Cure was defined as improvement clinically with subsidence of fever, and 
local signs, symptoms, decrease in WBC count and follow-up 
ultrasonography showed reduction in size < 3 cm in diameter and no 
evidence of relapses. Mean Hospital Stay was recorded.   
Patients were followed up for a minimum period of 3 months for recurrent 
attacks or development of complications and to monitor the efficacy of the 
treatment given. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PHOTOGRAPHS 
 
X ray showing an Air – fluid level in the liver. 
                                                       
CT showing the “Cluster sign” in a Pyogenic Liver abscess. 
 
 
 
 
 Percutaneous Aspiration of Pyogenic Liver Abscess being undertaken. 
 
Intraoperative Photograph of Liver Abscess showing the Abscess 
cavity. 
 
 
Observations and Results 
Patient data was collected using the proforma enclosed in the Annexure 
and tabulated using Microsoft Excel 2007.  
Tables and graphs were generated using the Microsoft Excel 2007. 
All statistical analysis was done using Winstats (v1.11) software. Standard 
deviation and Chi square test were used and ‘p’ value was determined. 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Table showing age and sex wise distribution of the studied 
population. 
Age Male Female Total Percentage 
18 -25 1 0 1 2 
26 -35 14 0 14 28 
36-45 12 0 12 24 
46-55 8 2 10 20 
56-65 11 2 13 26 
Total 46 4 50 100 
 
 
The studied population was between the age group of 18 to 65 years. The 
majority of the patients were in the age group of 26 - 35 years. The mean 
age of the patients was 44.8 years. Majority of the studied population were 
males     (92 %) with females constituting 8 %. 
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Table 2: Table showing the symptoms associated with liver abscess in 
the studied population. 
Symptom No of patients Percentage 
Abdominal pain 46 92 % 
Fever 39 78 % 
Jaundice 6 12 % 
Diarrhoea 8 16 % 
 
 
Abdominal pain was the most common symptom (92 %) present in patients 
with liver abscess. Fever was present in 78 % of the patients. 
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Table 3: Table showing the most common signs associated in patients 
with liver abscess. 
Signs Number of patients Percentage 
Tachycardia >100/min 22 44 
Hepatomegaly 23 46 
Rt intercostal tenderness 30 60 
 
 
Right lower intercostal tenderness was the most consistent sign and was 
present in 60 % of the patients while tachycardia (>100/min) was present in 
44 % and hepatomegaly was present in 46 % of the patients. 
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Table 4: Table showing the signs and symptoms of liver abscess, 
according to its aetiology. 
Signs and Symptoms Pyogenic Amoebic 
Abdominal Pain 97.22 % 78.57 % 
Fever 77.78 % 78.57 % 
Diarrhoea 11.11 % 28.57 % 
Jaundice 11.11 % 14.28 % 
Tachycardia >100/min 38.89 % 57.14 % 
Hepatomegaly 41.67 % 57.14 % 
Rt intercostal 
tenderness 
58.33 % 64.28 % 
 
 
Abdominal pain was the most consistent complaint in both pyogenic and 
amoebic liver abscess. Right lower intercostal tenderness was the most 
consistent sign in both pyogenic and amoebic liver abscess. 
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Table 5: Table showing the number of patients with deranged 
investigations in the studied population. 
Investigations Total Percentage 
Hb <9 16 32 
TC >11000 38 76 
Urea >40 20 40 
Creatinine >1.4 2 4 
 
 
76 % of the patients had a total count > 11,000. 40 % of patients had            
urea > 40mg/dl and 32 % had haemoglobin < 9 g/dl. 
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Table 6: Table showing the number of patients with deranged 
investigations in the studied population based on the type of liver 
abscess. 
Investigations Pyogenic Amoebic 
Hb <9 33.33 % 28.57 % 
TC >11000 77.78 % 71.43 % 
Urea >40 36.11 % 50 % 
Creatinine >1.4 2.78 % 7.14 % 
 
 
Total count > 11,000 cells/mm3 was seen in 77.8 % and 71.4 % of 
pyogenic and amoebic liver abscess respectively. Elevation of urea was 
more common in amoebic liver abscess compared to pyogenic liver 
abscess. 
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Table 7: Table showing the number of patients with abnormal liver 
function test parameters. 
Investigations Total Percentage 
T Bilirubin >3 6 12 % 
AST >40 42 84 % 
ALT >40 46 92 % 
SAP >115 17 34 % 
Albumin <3g/dl 16 32 % 
PT >20 s 3 6 % 
 
 
Most of the patients had elevation of AST and ALT levels. 32 % of 
patients had Albumin < 3 g/dl. 34 % of patients had elevation of Serum 
Alkaline phosphatase. 
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Table 8: Table showing the number of patients with abnormal liver 
function test parameters based on the type of liver abscess. 
Investigations Pyogenic Amoebic 
T Bilirubin >3 13.89 % 7.14 % 
AST >40 77.78 % 100 % 
ALT >40 91.67 % 92.86 % 
SAP >115 30.56 % 42.86 % 
ALB <3 27.78 % 42.86 % 
PT >20s 5.56 % 7.14 % 
 
 
All patients with amoebic abscess had elevation of AST. Elevation of AST 
and ALT were the most common parameter to be elevated in both amoebic 
and pyogenic liver abscesses. 
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Table 9: Table showing the distribution of patients based on the type 
of liver abscess. 
 Total Percentage 
Pyogenic 36 72 
Amoebic 14 28 
 
 
72 % of the studied population had pyogenic abscess while the remaining 
28 % had amoebic abscess. 
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Table 10: Table showing the distribution of patients in the studied 
population based on the lobe of involvement. 
 No. of Patients Percentage 
Right lobe 43 86 
Left lobe 4 8 
Bilateral 3 6 
Total 50 100 
 
 
Involvement of the right lobe was seen predominantly in 86% of cases. 
Isolated left lobe involvement was seen in 8 % of cases and 6 % had 
involvement of both lobes of liver. 
Right lobe 
Left lobe 
Bilateral 
Table 11: Table showing the distribution of patients in the studied 
population based on the lobe of involvement and the type of abscess. 
 Pyogenic Amoebic 
Right 83.33 % 92.86 % 
Left 8.33 % 7.14 % 
Bilobar 8.33 % 0 
 
 
Predominant right lobe involvement was seen in both pyogenic and 
amoebic abscess. Simultaneous involvement of both lobes was seen in 
pyogenic liver abscess only.  
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Table 12: Table showing the occurrence of liver abscess as a solitary or 
multiple lesions. 
 Total Percentage 
Solitary 45 90 
Multiple 5 10 
Total 50 100 
 
 
90% of the liver abscess occurred as a solitary lesion and the remaining 10 
% had multiple lesions. 
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Table 13: Table showing the occurrence of liver abscess as solitary or 
multiple lesions based on the aetiology. 
 Solitary Multiple 
Pyogenic 86.11 % 13.89 % 
Amoebic 100 % 0 
 
 
All of amoebic abscess in the studied population had a solitary lesion. All 
the multiple lesions were of pyogenic origin. 
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Table 14: Table showing the distribution of patients in the studied 
population based on the aetiology of pyogenic abscess. 
Aetiology Number Percentage 
Biliary 9 25 
Sepsis 1 2.8% 
Cryptogenic 26 72.2% 
Total 36 100 
 
 
72.2 % of the pyogenic abscess was of cryptogenic origin. Biliary origin of 
abscess was present in 25 % of cases. 
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Table 15: Table showing the bacteria isolated from blood culture in 
patients with liver abscess. 
Bacteria Number Percentage 
Klebsiella 10 47.6 
E coli 6 28.6 
Enterococci 5 23.8 
Total 21 100 
 
 
Blood culture was positive in 58.3 % of pyogenic abscess. Klebsiella was 
grown in 47.6 % of cases. E. coli was grown in 28.6 % of cases. 
Enterococci were isolated in 23.8 % of cases. 
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Table 16: Table showing the bacteria isolated from the culture of pus 
from patients with pyogenic liver abscess. 
Bacteria Number Percentage 
Klebsiella 10 52.6 
E coli 9 47.4 
Total 19 100 
 
 
Pus culture yielded growth in 52.8 % of pyogenic abscess. Klebsiella was 
the predominant organism, and was present in 52.6 % of cultures. E coli 
constituted 47.4 % of the cultures. 
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Table 17: Table showing the average size and volume of the abscess 
cavity based on the type of liver abscess. 
 Diameter Volume 
Pyogenic 8.4 310 
Amoebic 11.2 736 
 
Amoebic abscesses were larger with mean diameter of 11.2 cm to pyogenic 
abscesses with mean diameter 8.4 cm. The average volume of amoebic 
abscesses was 736 ml compared to 310 ml of pyogenic liver abscess. 
0 
2 
4 
6 
8 
10 
12 
Pyogenic Amoebic 
Diameter 
0 
100 
200 
300 
400 
500 
600 
700 
800 
Pyogenic Amoebic 
Volume 
Table 18: Table showing the number of aspirations required in 
successful treatment of liver abscess. 
 Number Percentage 
Single 21 84 
Twice 4 16 
 
 
Percutaneous aspiration was successful in all the patients employed where     
84 % were treated with a single aspiration and 16 % required aspiration 
twice. 
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Table 19: Table showing the common complications encountered in 
patients who underwent open surgical drainage of liver abscess. 
Complications Number Percentage 
Wound sepsis 12 48 % 
Atelectasis 6 24 % 
Bile leak 2 8 % 
Total 19  
 
 
76 % of the patients who underwent open surgical drainage developed 
complications. Wound sepsis (superficial surgical site infection) was 
encountered in 48 % patients who underwent open surgical drainage. Right 
basal atelectasis was seen in 24 % of cases and 8 % cases had postoperative 
bile leak. 
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Table 20: Table showing the mean values of the investigations done in 
patients with pyogenic and amoebic liver abscess. 
Investigations 
Pyogenic liver 
abscess 
S.D 
Amoebic liver 
abscess 
S.D 
Hemoglobin 9.5 0.69 9.5 0.93 
White Blood Cell 
count 
11.7 x 10
3 
1483 12.3 x 10
3 
1793 
Urea 38.6 8.73 37 8.7 
Creatinine 0.9 0.18 0.9 0.2 
Total Bilirubin 2 0.8 2.23 0.68 
SAP 103.4 26.58 119.1 34.6 
ALT 49.8 12.72 89.1 23.72 
AST 58.2 13.20 89.7 15.94 
Albumin 3.3 0.35 3.1 0.34 
Prothrombin time 15.4 2.73 15.8 2.42 
 
Patients with amoebic liver abscess had a marginal increase in mean values 
of WBC count compared to pyogenic liver abscess. The mean values of 
serum bilirubin, serum alkaline phosphatase, AST and ALT were higher in 
patients with amoebic liver abscess compared to pyogenic liver abscess. 
 
 
Table 21: Table showing the average size of liver abscess following 
aspiration and at follow up. 
 Size of Abscess Percentage 
At Aspiration 9.68 cm 100 
At Discharge 4.76 cm 49.2 
At 1 month of follow up 3.26 cm 33.7 
At 3 months of follow up 2.15 cm 22.2 
 
 
There was a 50 % reduction in the size of abscess following needle 
aspiration at discharge. Most of the patients had a residual abscess cavity at 
3 months of follow up. 
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Table 22: Table showing the average duration of stay in patients who 
underwent percutaneous aspiration and open surgical drainage. 
 
Aspiration Open Surgical Drainage 
Variable Mean Std. Dev. Mean Std. Dev. 
Duration of stay 14.16 3.21 21.68 2.36 
 
P = 0.03 
 
The average duration of stay was longer in patients who underwent open 
surgical drainage compared to percutaneous aspiration. The p value was < 
0.05 and hence the result was statistically significant. 
 
 
 
0 
5 
10 
15 
20 
25 
Aspiration Surgical Drainage 
Discussion 
Analysis of age and sex distribution. 
Majority of the patients were between the ages of 26 to 65 years. The mean 
age of the studied population was 44.8 years. Males constituted 92 % of the 
studied population. These results are in concordance with previous studies. 
Studies Mean age 
Giorgio et al 45.3 years (n = 115) 
Torres OJM et al
[44]
 45.2 years (n = 21) 
Rajak et al 35.5 years (n = 50) 
Present study 44.8 years (n = 50) 
 
Studies Male Female 
Giorgio et al 51.3 % 48.7 % 
Torres OJM et al 61.9 % 38.1 % 
Rajak et al 76 % 24 % 
Shyam mathur et al 96 % 4 % 
Present study 92 % 8 % 
 
Present study shows a high prevalence of liver abscess in males. This is 
also appreciated in other studies like Rajak et al and Shyam mathur et al. 
The prevalence of liver abscess seems to be equal among the sexes in 
studies outside India. 
Analysis of symptoms and signs. 
Pyogenic liver abscess 
Symptoms and signs Malik et al
[45]
 Yoo HM et al
[46]
 Present study 
Abdominal Pain 62% 84% 97.2 % 
Fever 91% 75% 77.8 % 
Diarrhoea 10% 13% 11.1 % 
Jaundice 34% 9% 8.3 % 
Hepatomegaly 65% 42% 41.7 % 
Abdominal tenderness 70% 88% 58.3 % 
 
Amoebic liver abscess 
Symptoms and signs Yoo HM et al Hayat et al
[47]
 Present study 
Abdominal Pain 90% 94% 78.6 % 
Fever 63% 78% 78.6 % 
Diarrhoea 15% 18% 28.6 % 
Jaundice 2% 10% 12 % 
Hepatomegaly 40% 48% 57.1 % 
Abdominal tenderness 88% 94% 64.3 % 
 
Right upper quadrant pain, fever and abdominal tenderness (right lower 
intercostal tenderness or epigastric tenderness) were the three most 
consistent findings in pyogenic liver abscess. Diarrhoea and jaundice were 
found in about 10% of the patients. In amoebic liver abscess, abdominal 
pain and fever were the most consistent findings. Hepatomegaly was more 
common in amoebic liver abscess probably due to the presence of larger 
abscesses compared to pyogenic group. 
Alcohol consumption was seen in 70% of the patients. Diabetes mellitus 
was prevalent in 10 % of the patients. 
Interpretation of Investigations. 
Pyogenic liver abscess 
Investigations Alexopoulou et al
[48]
 Yoo HM et al Present study 
Hemoglobin < 9g/dl - 25 % 33.3 % 
Leukocytosis 81.8 % 81 % 77.8 % 
T Bilirubin >2 mg/dl 24.2 % 25 % 30. 5 % 
AST >60 39.4 % 25 % 38.9 % 
ALT >60 - 25 % 25 % 
SAP >115 45.4 % 86 % 30.6 
ALB <3 45.4 % 49 % 27.8 
 
Leukocytosis was seen in 77.8 % of patients with pyogenic liver abscess. 
None of the other laboratory parameters were consistent with all patients. 
Amoebic liver abscesses also had associated leukocytosis. Elevation of 
AST and ALT was seen in more than 80 % patients of amoebic liver 
abscess, probably due to prolonged duration of the disease.  
Amoebic liver abscess 
Investigations Yoo HM et al Present study 
Hemoglobin < 9g/dl 17 % 28.6 % 
Leukocytosis 88 % 71.4 % 
T Bilirubin >2 10 % 21.4 % 
AST >60 11 % 92.8 % 
ALT >60 10 % 85.7 % 
SAP >115 76 % 42.8 % 
ALB <3 71 % 28.6 % 
 
Analysis of type of abscess. 
 Rajak et al Torres OJM et al Present study 
Pyogenic 22 % 57.1 % 72 
Amoebic 40 % 42.9 % 28 
Indeterminate 38 % - - 
 
Pyogenic abscess was more common than amoebic abscess in the studied 
population. Amoebic abscesses were common in the studies like Torres et 
al and Rajak et al which were conducted in the tropical countries. But the 
overall higher prevalence of pyogenic liver abscesses compared to the 
amoebic liver abscess in our study concur with other studies mentioned. 
Analysis of the lobe of involvement of abscess. 
 Rajak et al J. Rahimian
[49]
 A. Alexopoulou et al Present study 
Right 68 % 70.5 % 69.7 % 86 % 
Left 14 % 14.1 % 12.1 % 8 % 
Bilobar 18 % 5.1 % 18.2 % 6 % 
 
Liver abscess was common on the right lobe of liver. Left lobe abscess and 
bilobar involvement was seen in less than 10 % of cases. 
Analysis of the number of abscesses. 
 
Rajak et 
al 
Torres OJM et 
al 
A. Alexopoulou et 
al 
Present study 
Solitary 76 % 47.6 % 75.7 % 90 % 
Multiple 24 % 52.4 % 24.3 % 10 % 
 
Liver abscess tend to be solitary in our studied population as the majority 
of the liver abscess were cryptogenic. Multiple abscesses are more a 
feature of liver abscess which arise from a biliary aetiology. These findings 
are in concordance with studies of Rajak et al and A. Alexopoulou et al. 
Analysis of aetiology of pyogenic liver abscess. 
 J. Rahimian et al Yoo HM et al Present study 
Biliary 43 % 51 % 25 
Sepsis 5 % 3 % 2.8% 
Cryptogenic 48.1 % 38 % 72.2% 
 
Biliary sepsis like cholangitis was the predominant aetiological factor for 
pyogenic liver abscess in most of the studies. In our study, the predominant 
cause of pyogenic liver abscess remained cryptogenic. Cryptogenic 
abscesses occur in 10 – 45 % of the patients, depending on the extent of 
investigations used to identify the cause. 
[14]
 The patients in our study were 
not keen on pursuing further investigations as they became 
symptomatically better; the number of patients in the cryptogenic group 
remained high. 
 
Analysis of blood culture results. 
 S.C. Chen et al
[50]
 Khee-Siang Chan
[51]
 Present study 
Klebsiella sp 79.3 % 93.4 % 47.6 
E coli 12.3 % 6.6 % 28.6 
Enterococci 2 % - 23.8 
 
Blood culture from patients with pyogenic liver abscess yield a positive 
growth in about 50 – 60 % of cases. In our studied population 62 % of the 
patients with pyogenic abscess had a positive growth on culture. The most 
common organism isolated was klebsiella sp. The results concur with other 
studies like S. C. Chen et al and Khee-Siang Chan et al. Anaerobic cultures 
were not done in the study.  
Analysis of pus culture results. 
 Yoo HM et al K.L. Goh et al
[52]
 Present Study 
Klebsiella 24  % 25 % 52.6 
E coli 48.6 % 33.3 % 47.4 
Enterococci 10. 8 % 12.5 % - 
 
In contrast to blood cultures, pus from the abscess cavity yield growth in 
about 80 – 97 % of patients. [14] But in our study pus from the abscess 
cavity yielded growth in 60 % of the patients. Klebsiella was the most 
common organism cultured. In a few patients there was a difference in 
organism cultured from the abscess cavity and the blood of the same 
individual. This might be due to polymicrobial nature of liver abscess or 
due to administration of antibiotics prior to abscess drainage which might 
alter the pus culture results. Anaerobic cultures were not done in the study. 
Analysis of treatment. 
Percutaneous aspiration of the abscess was successful in all the patients. 16 
% of the patients required a second aspiration as the clinical improvement 
was marginal and significant amount of the residual abscess was present. 
Rajak et al had only 60 % success in their percutaneous aspiration group, 
while other studies had reported almost 100 % cure with minimal or no 
complications. 
 Rajak et al Giorgio et al Present study 
Single 44 % 92.3 % 84 
Twice 16 % 7.7 % 16 
 
Open surgical drainage was also successful in all the patients. But 
complications were encountered in 76 % of the patients ranging from local 
wound sepsis and self limiting bile leak. 
The duration of hospital stay was longer in patients who underwent open 
surgical drainage, partly due to the post operative complications that 
ensued.  
The patients were on follow up for a period of 3 months.  None of the 
patients had relapses or recurrences. 8 patients of the aspiration group did 
not come for follow up at the end of 3 months. Of the remaining 17 
patients, 4 patients had no demonstrable abscess cavity, while the other 
patients had a 78 % reduction in the size of the abscess cavity. As clinical 
improvement was considered as the end point of therapy, no further 
procedures were undertaken to these patients. Patients in the open surgical 
drainage group had no demonstrable abscess cavity at discharge. 
 
 
 
 
 
 
 
 
Conclusion 
Liver abscess occurred most commonly in age group of 26 to 65 years. 
Liver abscess was more common in males. Abdominal pain and fever were 
the most common presenting symptoms. Tachycardia and right intercostal 
tenderness were the common signs present in liver abscess. Leukocytosis 
was most common laboratory finding. Elevation of AST and ALT were the 
most common abnormality seen on liver function tests. 
Pyogenic liver abscess was the common type of liver abscess. Most of the 
abscesses were solitary and involved the right lobe of liver. 
Klebsiella species were the most common organisms isolated from blood 
culture and the pus culture. The cause of liver abscess remained obscure in 
most of the patients. 
Percutaneous needle aspiration is a safe interventional modality and was 
successful in all the patients. Open surgical drainage was also effective in 
all the patients employed. Surgical drainage was associated with post 
operative complications in 76 % of patients. 
Percutaneous needle aspiration is a better first line management in the 
treatment of liver abscess. Surgical drainage can be reserved for patients in 
whom percutaneous needle aspiration is unsuccessful. 
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A COMPARATIVE STUDY OF OPEN SURGICAL DRAINAGE AND EARLY 
PERCUTANEOUS NEEDLE ASPIRATION OF LIVER ABSCESS. 
 
PROFORMA 
 
Patient’s Name :                                                Age :           Sex :                                                                                                                                                                                                       
Occupation :                                                     Socio economic status :                                                  
Address :                                                           I.P No: 
  
  
 
D.O.A. : 
D.O.D. :                                                           Duration of stay in Hospital : 
 
 
CHIEF COMPLAINTS : 
 
HISTORY OF PRESENTING ILLNESS : 
 
Symptoms 
Abdominal pain : Yes / No 
• Duration : 
• Site : 
• Character : 
• Radiation : 
Fever : Yes / No 
• Duration : 
• Associated with chills and rigors : 
      Diarrhoea / Dysentery : 
• Duration : 
• Mucous diarrhoea : 
• Blood in stools : 
Vomiting : 
• Duration / Frequency : 
• Bilious : 
Jaundice :                                    Yes / No 
Cough :                                       Yes / No 
Distension of Abdomen :            Yes / No 
Altered Sensorium :                    Yes / No 
Any other : 
 
PAST HISTORY : 
Liver Abscess:                            Yes / No 
Gallstone disease:                       Yes / No 
Diarrhea :                                    Yes / No 
Jaundice :                                    Yes / No 
Tuberculosis:                               Yes / No 
Surgery :                                      Yes / No                     Comment: 
Trauma :                                      Yes / No                     Comment: 
 
FAMILY HISTORY : 
 
PERSONAL HISTORY : 
Diabetes Mellitus:                        Yes / No              Duration: 
Hypertension:                               Yes / No              Duration: 
 
ALCOHOL CONSUMPTION :   Yes / No 
Duration : 
Type :                                                                       Local Arrack: Yes / No 
Amount/Frequency: 
 
SMOKING :                                 Yes / No 
 
Appetite : 
Sleep : 
Bowel and Bladder : 
 
TREATMENT HISTORY : 
 
 
 
 
GENERAL PHYSICAL EXAMINATION : 
 
Build : 
Nourishment : 
 
Pallor :                                                  Jaundice :                                          Cyanosis : 
Clubbing :                                            Lymphadenopathy :                           Edema: 
Pulse :       /min 
B.P.             mm of Hg 
Respiration :                per minute 
Temperature : 
 
SYSTEMIC EXAMINATION : 
ABDOMEN : 
 
Shape : 
Umbilicus : 
Movements : 
Tenderness :                   Present / Absent 
Rigidity :                        Present / Absent 
Liver :                            Palpable / non palpable             Liver span :                    cm 
Surface : 
Right intercostal tenderness:     Present / Absent 
Spleen :                         Palpable / non palpable 
Scrotum / Testes : 
External Hernial Orifices : 
Free fluid: 
Bowel sounds : Present / Absent 
 Per Rectal Examination : 
 
RESPIRATORY SYSTEM : 
 
CARDIOVASCULAR SYSTEM : 
 
CENTRAL NERVOUS SYSTEM : 
 
INVESTIGATIONS : 
 
Blood :         
Group and Type: 
Hb :             gm% 
T.C. :           c/cmm 
D.C.:           N %,        L %,       E%,       M%,       B% 
ESR :          mm/hr 
BT : 
CT : 
Prothrombin time :          sec                 INR: 
 
RBS :                  mg/dl 
Blood urea :        mg/dl 
S creatinine :       mg/dl 
 
Urine : 
Albumin :          Yes / No 
Sugar :               Yes / No 
Microscopy : 
 
Stool : 
 
Ova / cyst : 
Occult blood :    Yes / No 
 
SPECIAL INVESTIGATIONS : 
 
Liver Function Tests : 
Bilirubin :                            ALP:                                      Total proteins : 
Direct:                                 ALT:                                       Albumin: 
Indirect:                               SAP:                                      Globulin: 
PT :                                                                                     A:G ratio : 
 
Blood Culture: 
 
HIV I AND II (ELISA) : 
 
HBsAg: 
 
RADIOLOGICAL INVESTIGATIONS : 
 Plain X-ray Chest PA View : 
 
Plain X-ray abdomen erect ; 
 
ULTRASONOGRAPHY ABDOMEN : 
 
Lobe of Involvement: 
Size: 
Ascites:  Yes / No 
Other Pathology: 
 
 
 
CT ABDOMEN: 
 
Lobe of Involvement: 
Size: 
Ascites:  Yes / No 
Other Pathology: 
 
 
OTHER INVESTIGATIONS : 
 
 
DIAGNOSIS : 
 
 
TREATMENT : 
 
Percutaneous aspiration / Surgery. 
 
 
 
COMMENTS : 
 
 
 
 
 
A COMPARATIVE STUDY OF OPEN SURGICAL DRAINAGE AND EARLY 
PERCUTANEOUS NEEDLE ASPIRATION OF LIVER ABSCESS. 
 
Proforma for percutaneous Aspiration. 
 
Patient Name:                                                                     Age:                        Sex: 
I. P. No: 
 
DOA:                          DOAspiration:                                DOD: 
 
Image Guidance: USG / CT 
 
Amount Aspirated: 
Type:           Amoebic / Pyogenic 
 
 
Pus Culture: 
Microscopy: 
 
Complications: 
 
 
USG 1 week After Aspiration: 
Size: 
 
Re-aspiration if done:      Yes / No 
Comment: 
 
 
Followup USG: 
 
Complications: 
 
Follow up Investigations: 
 
LFT: 
RFT: 
 
 
 
 
 
A COMPARATIVE STUDY OF OPEN SURGICAL DRAINAGE AND EARLY 
PERCUTANEOUS NEEDLE ASPIRATION OF LIVER ABSCESS. 
 
Proforma for surgical drainage: 
 
Patient Name:                                                                     Age:                        Sex: 
I. P. No: 
 
D O A:                          D O Surgery:                                D O D: 
 
Incision:                                                                             Anaesthesia: 
 
Drainage amount: 
Pus Type:          Amoebic / pyogenic 
Drain used: 
 
Post operative period: 
 
Pus Culture: 
 
Pus Microscopy: 
 
Complications: 
 
 
 
Followup USG: 
 
Followup Investigations: 
 
LFT: 
RFT: 
 
Comment: 
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1 ELUMALAI 90273 65 m 12 y    y  y y 94 9.8 10.8 34 1 2 0.6 1.4 76 34 45 3.6 13  
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5 PARAMASIVAN 7302 60 m 22 y    y   y 98 8.8 9.7 34 0.7 1.8 0.4 1.4 84 53 60 2.8 13 e coli 
6 BOOPALAN 7684 42 m 20 y    y    112 8.6 8.4 36 0.8 1.8 0.6 1.2 92 67 58 3 12  
7 PERIASWAMY 8575 56 m 16 y y   y  y y 104 10.2 12.6 38 1 2 0.8 1.2 104 34 42 3.5 14 ent 
8 CHELLAN 9344 60 m 18 y y   y   y 99 9 11.4 45 1.1 2.4 0.9 1.5 124 42 48 3.4 12 kleb 
9 MUTHU 9539 55 m 22 y      y  106 9.6 14 42 1 2.8 1.2 1.6 146 87 92 3 13  
10 PONNAMMAL 14961 46 f 23 y       y 98 8.8 9.8 42 0.9 1.3 0.4 0.9 96 35 54 2.8 12 ent 
11 ELANGOVAN 34578 50 m 13 y y y  y y y  108 9 13.8 41 0.9 2.8 1.8 1 154 125 99 2.8 14  
12 SIVAKUMAR 45162 32 m 9 y y  y y  y  114 8.6 12.8 54 1.4 3.8 1.6 2.2 168 112 104 2.8 14  
13 MAHESH 45426 26 m 19 y y   y   y 110 9.2 8.4 49 1.3 2.1 0.9 1.2 122 64 68 3 15  
14 ETTIAPPAN 49384 34 m 15 y y   y    96 9.8 11.8 32 0.7 1.8 0.6 1.2 98 47 54 4 21 kleb 
15 SUBRAMANI 74817 45 m 21 y        98 9.6 9.9 28 0.7 2 0.6 1.4 94 88 94 3.2 18  
16 ARJUNAN 67 28 m 17  y   y  y y 96 9.8 10.9 25 0.6 2.4 0.5 1.9 112 94 92 3.5 16  
17 KUPPUSWAMY 149 22 m 24 y y   y    102 10 12.5 42 1 1.4 0.4 1 84 46 53 3.6 19 ent 
18 VENUGOPAL 675 62 m 23 y    y  y y 104 8.8 13 44 1.1 2.6 0.6 2 108 78 85 3 17  
19 GOPAL 830 58 m 16 y y   y   y 93 9 13.4 22 0.7 1.2 0.5 0.7 104 46 52 3 16  
20 VEERASWAMY 1845 49 m 20 y y y  y y y  96 9.2 12.6 43 1 2.1 0.7 1.4 98 31 46 3.1 19 e coli 
21 CHANDRAMMAL 2350 36 m 28 y y  y y  y y 102 9.2 10.8 56 1.4 3.6 1.6 2 162 28 38 3.2 15 kleb 
22 CHOKKAMMAL 2673 57 f 24  y      y 92 8.8 9.4 48 1 2.2 0.7 1.5 88 73 84 3 14 kleb 
23 PERUMAL 4360 61 m 22 y y y  y    100 8 8.3 38 1 2 0.6 1.4 84 87 92 2.6 12  
24 VENKATESAN 4629 34 m 21 y y y y    y 104 9 11.8 54 1.1 4 1.6 2.4 188 54 66 2.8 13 e coli 
25 MURUGAN 5931 56 m 21 y    y  y  90 9.4 13.4 38 0.9 1.8 0.8 1 82 38 54 3 16  
26 RAJESH 6028 29 m 13 y y   y   y 84 9.6 14.2 38 0.8 1.6 0.7 0.9 65 46 58 3.2 18  
27 KARUNAKARAN 6437 34 m 13 y y y  y  y y 98 9.6 11.4 24 0.7 2.4 0.9 1.5 122 98 100 3.2 16  
28 BASKAR 7394 38 m 20 y    y  y y 92 9.8 11.2 36 0.9 1.4 0.6 0.8 72 46 49 3.5 15  
29 BALAN 8142 45 m 21 y y       103 10.2 9.8 24 0.7 1.8 0.5 1.3 78 58 62 3.8 18 kleb 
30 MUNISWAMY 8353 57 m 25 y y   y  y  116 10 12.2 38 1 1 0.2 0.8 80 56 63 4 22  
31 LOGANATHAN 8503 63 m 22 y y   y   y 102 8 12.8 40 1 2.6 0.8 1.8 86 102 98 2.8 14  
32 MUNIAMMAL 9148 31 f 19 y y     y  98 9.8 11.6 34 0.9 1.4 0.4 1 88 65 72 3.1 15 e coli 
33 MUTHUKUMAR 9573 44 m 12 y y      y 108 8.2 11.4 28 0.8 1.6 0.5 1.1 94 57 62 2.8 14  
34 KUMAR 11672 64 m 15 y y   y    96 9 13.4 30 1 2.8 1 1.8 132 44 54 3.4 14 ent 
35 APPADORAI 13591 59 m 14 y  y  y y y y 108 9.2 12.8 48 1.2 1 0.3 0.7 64 72 84 3 13  
36 NATARAJ 26271 29 m 12 y y      y 112 10 13.2 35 0.8 1.6 0.3 1.3 78 92 88 3.5 18  
37 KRISHNAN 28556 42 m 16 y y  y y  y  96 9.6 11.8 56 1 3.6 1.4 2.2 144 58 53 3.2 17 kleb 
38 SHEKAR 33524 37 m 14  y   y   y 92 10 14.2 47 0.8 2.1 0.9 1.2 184 120 114 3.8 15  
39 CHINNAPAIYAN 35292 46 m 19 y y  y y  y  90 10.2 14 25 0.7 4.2 1 3.2 92 64 78 3.4 14 ent 
40 ELUMALAI 36993 45 m 21 y y      y 110 10 14 31 0.7 1.6 0.7 0.9 102 59 65 3.5 17 e coli 
41 BABU 37230 36 m 11 y y   y  y  98 10.2 11.2 42 1 2.1 0.8 1.3 118 64 84 3.6 19  
42 KASIYAMMAL 43489 54 f 22 y y y     y 104 9 10.4 29 0.9 1.4 0.6 0.8 96 42 36 3 18  
43 PONNUSWAMY 46425 52 m 20 y y    y y y 96 9.8 12.6 36 1 1.2 0.5 0.7 128 62 56 3.2 14 kleb 
44 PARTHIBAN 60273 28 m 9 y    y    112 12 11 52 1.2 3 1.4 1.6 110 36 64 3.1 18  
45 ALAGESAN 65833 34 m 15  y  y y  y y 88 11 10.4 40 0.9 1.4 0.8 0.6 145 72 78 3 21  
46 BOOPATHI 68564 38 m 23 y y   y    94 10.2 13 38 0.8 1.5 0.7 0.8 98 42 54 3.4 15 kleb 
47 KESAVAN 73466 29 m 12 y y y    y y 104 9.8 12.8 28 0.7 1.2 0.6 0.6 84 38 48 3.2 18  
48 KADIRESAN 79230 31 m 19 y y   y   y 96 11 14 34 1 1.6 0.6 1 102 54 72 3.5 15  
49 RANGANATHAN 83482 52 m 20 y y   y  y y 84 9 12 41 1.2 2 0.8 1.2 118 69 84 3.8 19 e coli 
50 PRABHU 98263 34 m 13 y y   y    98 10 11 30 1 1.4 0.8 0.6 88 31 34 3.2 13  
 
Continued on next page... 
MASTER CHART (continued) 
Si No Name IP No LOBE SIZE SOL/MUL PYO/AMOE Treatment No of Asp cause pus c/s Complications At discharge At 1 month At 3 months 
1 ELUMALAI 90273 R 8 S P Asp 1 crypt  Nil 6 4 2 
2 DAMODHARAN 374 R 10 S P Asp 1 crypt e coli Nil 4 dnf dnf 
3 KUPPAN 932 R 9 S P Asp 1 crypt kleb Nil 5 dnf dnf 
4 ARAIMMAL 4859 R 8 S P Sur  biliary kleb A    
5 PARAMASIVAN 7302 R 8 M P Sur  crypt e coli W + A    
6 BOOPALAN 7684 L 6 S P Sur  crypt e coli Nil    
7 PERIASWAMY 8575 R 8 S P Asp 1 crypt  Nil 6 4 3 
8 CHELLAN 9344 R 8 S P Sur  biliary e coli W    
9 MUTHU 9539 R 12 S A Sur  amoebic  W + A    
10 PONNAMMAL 14961 R 9 S P Sur  crypt  NIL    
11 ELANGOVAN 34578 R 11 S A Asp 1 amoebic  Nil 5 3 2 
12 SIVAKUMAR 45162 R 12 S A Asp 1 amoebic  Nil 4 3 no cavity 
13 MAHESH 45426 R 9 S P Sur  biliary kleb W    
14 ETTIAPPAN 49384 R 8 S P Asp 1 crypt kleb Nil 6 5 3 
15 SUBRAMANI 74817 R 10 S A Sur  amoebic  NIL    
16 ARJUNAN 67 R 13 S A Asp 1 amoebic  Nil 4 2 2 
17 KUPPUSWAMY 149 L 8 S P Sur  crypt  W    
18 VENUGOPAL 675 R 10 S A Sur  amoebic  NIL    
19 GOPAL 830 R 10 S P Asp 1 crypt e coli Nil 6 4 dnf 
20 VEERASWAMY 1845 R 9 S P Asp 1 biliary e coli Nil 6 5 dnf 
21 CHANDRAMMAL 2350 R 8 S P Sur  biliary  A + B    
22 CHOKKAMMAL 2673 B 8 M P Sur  sepsis kleb W    
23 PERUMAL 4360 L 8 S A Sur  amoebic  NIL    
24 VENKATESAN 4629 R 9 S P Asp 2 biliary e coli Nil 4 dnf dnf 
25 MURUGAN 5931 R 8 S P Sur  crypt  W + A    
26 RAJESH 6028 R 10 S P Asp 1 crypt kleb Nil 5 3 2 
27 KARUNAKARAN 6437 R 12 S A Asp 1 amoebic  Nil 6 4 2 
28 BASKAR 7394 R 9 M P Sur  biliary  B    
29 BALAN 8142 R 8 S P Sur  crypt  W    
30 MUNISWAMY 8353 R 8 S P Sur  crypt kleb A    
31 LOGANATHAN 8503 R 11 S A Sur  amoebic  W    
32 MUNIAMMAL 9148 R 7 S P Sur  crypt  NIL    
33 MUTHUKUMAR 9573 R 8 S P Asp 1 crypt kleb Nil 3 3 no cavity 
34 KUMAR 11672 R 10 S P Asp 1 biliary e coli Nil 4 3 2 
35 APPADORAI 13591 B 8 M P Asp 2 crypt  Nil 5 dnf dnf 
36 NATARAJ 26271 R 13 S A Asp 1 amoebic  Nil 6 4 2 
37 KRISHNAN 28556 R 7 S P Asp 1 crypt kleb Nil 4 2 no cavity 
38 SHEKAR 33524 R 12 S A Asp 1 amoebic  Nil 3 dnf dnf 
39 CHINNAPAIYAN 35292 R 9 S P Sur  crypt  W    
40 ELUMALAI 36993 R 8 S P Asp 2 crypt  Nil 5 3 2 
41 BABU 37230 R 8  P Asp  crypt - Nil 4 3 2 
42 KASIYAMMAL 43489 R 9  P Sur  crypt - NIL    
43 PONNUSWAMY 46425 R 8  P Sur  crypt - NIL    
44 PARTHIBAN 60273 L 10  P Asp  crypt - Nil 5 3 2 
45 ALAGESAN 65833 R 10  A Asp  amoebic - Nil 5 dnf dnf 
46 BOOPATHI 68564 R 9  P Sur  crypt kleb W    
47 KESAVAN 73466 R 11  A Asp  amoebic - Nil 4 2 2 
48 KADIRESAN 79230 R 12  A Sur  amoebic - NIL    
49 RANGANATHAN 83482 B 8  P Sur  biliary e coli W    
50 PRABHU 98263 R 8  P Asp  crypt - Nil 4 2 no cavity 
 
